Cannabis for Cancer

How Does Medical Cannabis Support Cancer Treatment?

The role of medical cannabis in oncology has increasingly come into the focus of scientific research in recent years. As demonstrated by the meta-analysis of Castle et al. (2025), there is significant scientific support for the use of medical cannabis both in palliative care and as a potentially anticarcinogenic agent. The results from over 10,000 studies containing a total of 39,767 relevant data points show that the supportive effect of cannabis in the context of cancer treatment is 31.38 times more strongly evidenced than opposing statements.

Cannabis primarily supports cancer therapy by alleviating therapy-related side effects such as pain, nausea, and loss of appetite. Furthermore, preclinical studies show a growth-inhibiting effect on tumor cells, with cannabinoids like THC and CBD being able to induce apoptosis (programmed cell death) and inhibit the proliferation of cancer cells. Learn more about CBD in cancer.

The therapeutic potentials mainly arise from the interaction of cannabinoids with the body's own endocannabinoid system, which plays a regulatory role in both the central nervous system and the immune system. By activating CB1 and CB2 receptors, painful and inflammatory processes can be modulated. The analysis shows that 71.4% of the articles in the overall review exhibit a predominantly positive sentiment toward medical cannabis.

What Are the Health Effects of Medical Cannabis in Cancer Treatments?

The health effects of cannabis in cancer treatments can be divided into three main categories: health metrics (e.g., inflammation, therapeutic benefit), cancer therapies (e.g., chemotherapy, immunotherapy, pain management), and cancer dynamics (e.g., tumor growth, apoptosis, remission). The meta-analysis differentiates these categories and assigns each relevant topic a significant correlation with positive or negative sentiments.

The supportive effect is particularly pronounced in the category of health metrics. The correlation between cannabis and therapeutic effects shows a 46.98-fold stronger tendency in favor of supportive statements compared to non-supportive ones. This indicates a very high level of scientific consensus regarding the health-promoting properties of cannabis. Notably, the therapeutic effect reaches a very high degree of statistical significance with a correlation value of 0.48.

Side effects are also discussed in the literature but are reported less frequently and less strongly than positive effects. In the sentiment analysis, negative statements accounted for only 25.6% of the articles, while unclear results played a minor role at just 3%.

How Does Cannabis Affect Inflammation in the Body?

Inflammation plays a central role in cancer development and progression. Chronic inflammatory processes can not only promote tumor growth but also impair the body's immune response to cancer cells. In this context, the anti-inflammatory effect of medical cannabis is of particular importance. The meta-analysis by Castle et al. (2025) clearly shows that studies dealing with cannabis in connection with inflammatory processes are highly likely to report a supportive effect. The correlation value for anti-inflammatory effects was 0.077 (p < 1.33 × 10⁻¹⁵), indicating very strong statistical significance.

Cannabinoids such as CBD (cannabidiol) and THC (tetrahydrocannabinol) modulate the immune system through various mechanisms. They interact with CB2 receptors, which are primarily found on immune cells, and can inhibit the production of proinflammatory cytokines there. These anti-inflammatory properties are not only important for reducing accompanying symptoms but may also exert a direct cancer-inhibiting effect by modulating the tumor-promoting inflammatory environment.

An especially interesting aspect of the meta-analysis is the inverse correlation between "not supported" sentiments and the topic "inflammatory" in the dominance analysis. This means that studies addressing inflammation in the context of cannabis report significantly fewer negative results. This evidence base justifies the assumption that medical cannabis not only alleviates symptoms but can also play a protective role at the pathophysiological level.

What Role Does Cannabis Play in Pain Management in Cancer Therapy?

Pain is one of the most common and distressing symptoms in cancer patients, especially in advanced stages of the disease. Opioids are considered the gold standard in pain therapy but are associated with significant side effects and addiction potential. Here, medical cannabis presents a promising alternative or complement.

The meta-analysis records one of the strongest positive correlations with supportive sentiments for the topic "Pain" in the entire study. The correlation value of 0.156 (p < 7.53 × 10⁻⁵⁹) in the keyword occurrence analysis, as well as a similarly high value in the dominance analysis, indicate a pronounced scientific consensus. Studies report that cannabinoids act on the nociceptive system, particularly through activation of CB1 receptors in the central nervous system, leading to a reduction in pain sensations.

Another advantage of medical cannabis is the possibility to reduce opioid use. Individual studies suggest that patients using cannabis medication less frequently require high doses of opioids, which can reduce the risk of side effects and dependency. Although further research is needed on this interaction, the meta-analysis shows that the majority of studies report a positive effect on pain management.

Noteworthy is also the low frequency of negative reports: only a small portion of studies addressed adverse effects such as paranoia or nervousness, and even these mostly occurred in moderate intensity. This supports the good tolerability of cannabis in pain therapy for oncology patients.

How Is Cannabis Used as Supportive Treatment During Chemotherapy?

Chemotherapy remains one of the central pillars of cancer therapy but is often associated with severe side effects. These primarily include nausea, vomiting, loss of appetite, and fatigue. Medical cannabis has established itself as one of the most effective complementary measures to alleviate these side effects and improve quality of life during treatment.

In the meta-analysis, the topic "Chemotherapy" showed a very strong association with supportive sentiments. The correlation value was 0.088 (p < 1.33 × 10⁻¹⁹), indicating clear and robust evidence. Cannabis is particularly frequently used to relieve chemotherapy-induced nausea and vomiting (CINV). THC acts via CB1 receptors in the brain, which are responsible, among other things, for regulating nausea and appetite. CBD appears to modulate THC’s effects and can enhance anxiolytic effects.

Furthermore, there is evidence that patients using cannabis alongside chemotherapy tolerate the treatment better and are less likely to discontinue it. This may also have psychosomatic reasons, as cannabis positively influences not only physical well-being but also mood, sleep quality, and overall resilience.

The analysis also highlights that supportive statements regarding cannabis use in connection with chemotherapy occur significantly more frequently than negative or unclear assessments. The dominance analysis shows a clear trend: studies on chemotherapy and cannabis are highly likely to report positive effects. This underlines the clinical benefit as a palliative adjunct in standard oncological therapy.

Does Cannabis Have Anticarcinogenic Properties?

The potentially anticarcinogenic effect of cannabis is one of the most exciting and simultaneously controversial research areas in oncology. The meta-analysis by Castle et al. (2025) confirms that an increasing number of preclinical and some clinical studies provide evidence that certain cannabinoids—especially THC and CBD—can directly affect tumor cell growth.

The analyzed data show that the topic "Anticarcinogenic" has a correlation value of 0.088 (p < 7.17 × 10⁻²⁰), indicating a highly significant association with supportive sentiments. Among other findings, studies describe that cannabinoids induce apoptosis (programmed cell death of cancer cells), inhibit angiogenesis (the formation of new blood vessels that supply tumors with nutrients), and block signaling pathways critical for malignant cell growth.

The picture varies particularly by cancer type: certain breast cancer subtypes appear sensitive to THC- or CBD-containing therapies, while other tumors such as glioblastomas, pancreatic carcinomas, or prostate cancer involve different receptor profiles. The so-called "entourage effect"—the synergistic action of multiple cannabinoids and terpenes—is increasingly considered therapeutically relevant.

However, the meta-analysis also emphasizes that many of these effects have so far been demonstrated mainly in vitro or in vivo in animal studies. Clinically robust data in humans are scarce and urgently needed. Nevertheless, the quantitative evaluation shows that the scientific community increasingly recognizes the anticarcinogenic potential of cannabis—without becoming uncritical.

How Is Cannabis Used to Increase Appetite During Cancer Treatments?

Loss of appetite and unintended weight loss are common accompanying symptoms of oncological diseases, especially during chemotherapy. The so-called "anorexia-cachexia syndrome" can significantly worsen prognosis. Medical cannabis is used here because its effect on the endocannabinoid system can modulate essential bodily functions such as hunger and metabolism.

The meta-analysis assigns the topic "Appetite" a correlation value of 0.066 (p < 5.91 × 10⁻¹²)—a clear indication of consistent positive study results. THC activates CB1 receptors in the hypothalamus, stimulating the feeling of hunger. CBD also appears to support this, mainly by modulating serotonergic and dopaminergic systems that influence eating behavior.

Many patients report a noticeable increase in appetite and weight stabilization in clinical studies. Although there are some studies with inconsistent results—depending on cancer type, dosage, or individual response—the sentiment analysis shows a clear majority of positive assessments.

Notably, the dominance analysis found no significant "not supported" or "unclear" results. This underscores the clinical relevance and potential standardization of cannabis as a supportive measure to promote appetite in cancer patients.

How Is Cannabis Used to Relieve Chemotherapy-Induced Nausea?

Chemotherapy-induced nausea and vomiting (CINV) are among the most distressing side effects for cancer patients. Even modern antiemetics often do not fully suppress these symptoms. Cannabis has been used in this context since the 1980s—sometimes in synthetic form (e.g., dronabinol), sometimes as an extract.

The current meta-analysis confirms this tradition with impressive statistical clarity: the topic "Nausea" shows a correlation of 0.079 (p < 2.95 × 10⁻¹⁶), indicating a stable evidence base. Cannabinoids act via CB1 receptors in the brainstem, where they influence the neural pathways that trigger nausea and vomiting.

Subjective patient reports also confirm these results. Many state that they feel significantly better with cannabis treatment, experience less vomiting, and thus improve therapy adherence. The analysis also notes that both keyword-based and dominant sentiment analyses show no significant negative results—strong evidence for acceptance and effectiveness in practice.

How Does Cannabis Affect Tumor Growth and Tumor Size?

A central goal of modern oncology is not only symptom control but also the direct inhibition of tumor growth. This raises the question of whether cannabis, beyond its immunomodulatory and cell-regulating effects, also acts as a tumor inhibitor. The meta-analysis addresses this question through the categories "Tumor growth" and "Tumor size."

Both topics show significant positive correlations with supportive study results. "Tumor growth" has a correlation value of 0.037 (p < 0.0001), and "Tumor size" 0.022 (p < 0.025). These figures suggest increasing evidence that cannabinoids inhibit tumor cell proliferation and slow the growth of existing tumors in preclinical models.

Mechanistically, this is explained by various effects: inhibition of cell cycle progression, induction of autophagy, influence on gene expression of oncogenic signaling pathways, and an anti-inflammatory microenvironment that hinders tumor growth. Inhibition of tumor angiogenesis also plays a role by reducing the tumor’s nutrient supply.

However, it should be noted that these findings mainly come from animal models and cell culture studies. Clinical studies in humans are still pending. Nevertheless, dominant sentiment analyses show a stable pattern favoring a supportive effect, while opposing statements rarely reach significance.

What Does Research Show About the Long-Term Effects of Cannabis Use in Cancer Treatment?

The long-term effects of medical cannabis use in cancer patients have so far been only limitedly studied. The meta-analysis addresses this mainly through the distribution of sentiments across the entire literature corpus. Here, an impressively consistent tendency in favor of supportive statements is evident—both regarding acute effects and longer-term observations.

Of a total of 10,641 analyzed studies, over 71% were characterized by a supportive sentiment. The likelihood that a study describes a supportive effect of cannabis was more than 31 times higher than the opposite. This speaks to a consistent positive assessment—even considering potential limitations such as publication bias or study heterogeneity.

At the same time, the analysis emphasizes the need for further research to systematically capture long-term effects—especially regarding mental health, addiction risks, and interactions with other medications. Currently, there is no evidence of serious long-term damage in the oncological context, but the evidence base in this regard still needs to be expanded.